Robot Assisted Treatment Versus Conventional Surgery for Tile B and C Pelvic Fractures

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJunbo Liang

About this trial

This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted treatment versus conventional surgery in patients with Tile B and C pelvic fractures. Eligible patients will be stratified according to Tile fracture classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or conventional surgical treatment. Primary and secondary outcomes include pain relief, early mobilization, functional recovery, imaging outcomes, perioperative complications, venous thromboembolism events, laboratory parameters, opioid consumption, and healthcare resource utilization. The study aims to provide evidence for optimizing surgical treatment strategies for unstable pelvic fractures.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagnosis of Tile B or Tile C pelvic fracture

Injury duration less than 3 weeks

Ability to provide written informed consent

Disqualifiers

Severe open injury or skin infection at the surgical site

Hemodynamic instability preventing anesthesia or surgery

Severe psychiatric disorders or dementia

Severe obesity affecting imaging quality

Trial design

Treatments tested in this trial

  • Robot Assisted Minimally Invasive Fixation

Treatment groups

88 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Junbo Liang

Lead sponsor

Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University

Sponsor institution